OTCMKTS:ALNRF - Mediclinic International Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$12.29
+0.30 (1.20%)
Get New Mediclinic International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALNRF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALNRF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Mediclinic International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $12.29.
N/A
The current consensus among 0 polled investment analysts is to n/a stock in Mediclinic International. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/7/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/6/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/30/2017Jefferies Financial GroupUpgradeUnderperform ➝ Buy
i
(Data available from 3/1/2016 forward)
Mediclinic International logo
Read More

Today's Range

Now: $12.29
$12.29
$12.29

50 Day Range

MA: N/A

52 Week Range

Now: $12.29
$12.29
$12.29

Volume

225,623 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Mediclinic International?

The following Wall Street analysts have issued research reports on Mediclinic International in the last twelve months:
View the latest analyst ratings for ALNRF.

What is the current price target for Mediclinic International?

0 Wall Street analysts have set twelve-month price targets for Mediclinic International in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Mediclinic International in the next year.
View the latest price targets for ALNRF.

What is the current consensus analyst rating for Mediclinic International?

Mediclinic International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ALNRF.